{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:26:02Z","timestamp":1791419162019,"version":"4.3.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-02039-2","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:35:15Z","timestamp":1769106915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The discordance of remnant cholesterol and low-density lipoprotein cholesterol as a predictor of diabetes, diabetic microvascular diseases, and cardiovascular disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Yao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangya","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangming","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niluo","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"2039_CR1","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/dc25-S002","volume":"48","author":"Diagnosis and Classification of Diabetes","year":"2025","unstructured":"Diagnosis and Classification of Diabetes. Standards of care in Diabetes-2025. Diabetes Care. 2025;48:S27\u201349. https:\/\/doi.org\/10.2337\/dc25-S002.","journal-title":"Diabetes Care"},{"key":"2039_CR2","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/s0140-6736(24)02317-1","volume":"404","author":"Worldwide trends in diabetes prevalence and treatment","year":"2024","unstructured":"Worldwide trends in diabetes prevalence and treatment. From 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404:2077\u201393. https:\/\/doi.org\/10.1016\/s0140-6736(24)02317-1.","journal-title":"Lancet"},{"key":"2039_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113798","author":"S Rayego-Mateos","year":"2020","unstructured":"Rayego-Mateos S, Morgado-Pascual JL, Opazo-R\u00edos L, Guerrero-Hue M, Garc\u00eda-Caballero C, V\u00e1zquez-Carballo C, et al. Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21113798.","journal-title":"Int J Mol Sci"},{"key":"2039_CR4","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.ophtha.2018.04.007","volume":"125","author":"TY Wong","year":"2018","unstructured":"Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, et al. Guidelines on diabetic eye care: the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology. 2018;125:1608\u201322. https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.007.","journal-title":"Ophthalmology"},{"key":"2039_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","volume":"16","author":"JB Cole","year":"2020","unstructured":"Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16:377\u201390. https:\/\/doi.org\/10.1038\/s41581-020-0278-5.","journal-title":"Nat Rev Nephrol"},{"key":"2039_CR6","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx N, Federici M, Sch\u00fctt K, M\u00fcller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44:4043\u2013140. https:\/\/doi.org\/10.1093\/eurheartj\/ehad192.","journal-title":"Eur Heart J"},{"key":"2039_CR7","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2337\/dc19-2292","volume":"43","author":"I Bebu","year":"2020","unstructured":"Bebu I, Schade D, Braffett B, Kosiborod M, Lopes-Virella M, Soliman EZ, et al. Risk factors for first and subsequent CVD events in type 1 diabetes: the DCCT\/EDIC study. Diabetes Care. 2020;43:867\u201374. https:\/\/doi.org\/10.2337\/dc19-2292.","journal-title":"Diabetes Care"},{"key":"2039_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2337\/db21-0490","volume":"71","author":"NA Yousri","year":"2022","unstructured":"Yousri NA, Suhre K, Yassin E, Al-Shakaki A, Robay A, Elshafei M, et al. Metabolic and metabo-clinical signatures of type 2 Diabetes, obesity, retinopathy, and dyslipidemia. Diabetes. 2022;71:184\u2013205. https:\/\/doi.org\/10.2337\/db21-0490.","journal-title":"Diabetes"},{"key":"2039_CR9","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/cir.0000000000000678","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of Cardiology\/American heart association task force on clinical practice guidelines. Circulation. 2019;140:e596-646. https:\/\/doi.org\/10.1161\/cir.0000000000000678.","journal-title":"Circulation"},{"key":"2039_CR10","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/s0140-6736(10)61350-5","volume":"376","author":"C Baigent","year":"2010","unstructured":"Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive Lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670\u201381. https:\/\/doi.org\/10.1016\/s0140-6736(10)61350-5.","journal-title":"Lancet"},{"key":"2039_CR11","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/eurheartj\/ehac783","volume":"44","author":"PE St\u00fcrzebecher","year":"2023","unstructured":"St\u00fcrzebecher PE, Katzmann JL, Laufs U. What is \u201cremnant cholesterol\u201d? Eur Heart J. 2023;44:1446\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehac783.","journal-title":"Eur Heart J"},{"key":"2039_CR12","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","volume":"76","author":"O Casta\u00f1er","year":"2020","unstructured":"Casta\u00f1er O, Pint\u00f3 X, Subirana I, Amor AJ, Ros E, Hern\u00e1ez \u00c1, et al. Remnant Cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease. J Am Coll Cardiol. 2020;76:2712\u201324. https:\/\/doi.org\/10.1016\/j.jacc.2020.10.008.","journal-title":"J Am Coll Cardiol"},{"key":"2039_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59173-6","volume":"14","author":"PT Yang","year":"2024","unstructured":"Yang PT, Tang L, Yang SQ, Shi QL, Wang YQ, Qin YX, et al. Remnant cholesterol trajectory and subclinical arteriosclerosis: a 10-year longitudinal study of Chinese adults. Sci Rep. 2024;14:9037. https:\/\/doi.org\/10.1038\/s41598-024-59173-6.","journal-title":"Sci Rep"},{"key":"2039_CR14","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1016\/j.jacc.2020.10.029","volume":"76","author":"JR Burnett","year":"2020","unstructured":"Burnett JR, Hooper AJ, Hegele RA. Remnant Cholesterol and atherosclerotic cardiovascular disease risk. J Am Coll Cardiol. 2020;76:2736\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2020.10.029.","journal-title":"J Am Coll Cardiol"},{"key":"2039_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111724","volume":"202","author":"H Liu","year":"2021","unstructured":"Liu H, Hu W, Li X, Hu F, Xi Y, Su Z, et al. Do perfluoroalkyl substances aggravate the occurrence of obesity-associated glucolipid metabolic disease? Environ Res. 2021;202:111724. https:\/\/doi.org\/10.1016\/j.envres.2021.111724.","journal-title":"Environ Res"},{"key":"2039_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12933-022-01554-0","volume":"21","author":"X Hu","year":"2022","unstructured":"Hu X, Liu Q, Guo X, Wang W, Yu B, Liang B, et al. The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus. Cardiovasc Diabetol. 2022;21:117. https:\/\/doi.org\/10.1186\/s12933-022-01554-0.","journal-title":"Cardiovasc Diabetol"},{"key":"2039_CR17","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/eurjpc\/zwae102","volume":"31","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Madsen JM, \u00d6zbek BT, K\u00f8ber L, Bang LE, L\u00f8nborg JT, et al. The role of remnant cholesterol in patients with ST-segment elevation myocardial infarction. Eur J Prev Cardiol. 2024;31:1227\u201337. https:\/\/doi.org\/10.1093\/eurjpc\/zwae102.","journal-title":"Eur J Prev Cardiol"},{"key":"2039_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/clinchem\/hvae222","volume":"71","author":"BN Wadstr\u00f6m","year":"2025","unstructured":"Wadstr\u00f6m BN, Wulff AB, Pedersen KM, Nordestgaard BG. Small remnants versus large triglyceride-rich lipoproteins in risk of atherosclerotic cardiovascular disease. Clin Chem. 2025;71:463\u201373. https:\/\/doi.org\/10.1093\/clinchem\/hvae222.","journal-title":"Clin Chem"},{"key":"2039_CR19","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1007\/s00125-023-06016-0","volume":"66","author":"BN Wadstr\u00f6m","year":"2023","unstructured":"Wadstr\u00f6m BN, Pedersen KM, Wulff AB, Nordestgaard BG. Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study. Diabetologia. 2023;66:2238\u201349. https:\/\/doi.org\/10.1007\/s00125-023-06016-0.","journal-title":"Diabetologia"},{"key":"2039_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2337\/dc22-1550","volume":"46","author":"JH Huh","year":"2023","unstructured":"Huh JH, Roh E, Lee SJ, Ihm SH, Han KD, Kang JG. Remnant cholesterol is an independent predictor of type 2 diabetes: a nationwide population-based cohort study. Diabetes Care. 2023;46:305\u201312. https:\/\/doi.org\/10.2337\/dc22-1550.","journal-title":"Diabetes Care"},{"key":"2039_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1334886","volume":"14","author":"X Meng","year":"2023","unstructured":"Meng X, Xu H, Liang Y, Liang M, Song W, Zhou B, et al. Enhanced CT-based radiomics model to predict natural killer cell infiltration and clinical prognosis in non-small cell lung cancer. Front Immunol. 2023;14:1334886. https:\/\/doi.org\/10.3389\/fimmu.2023.1334886.","journal-title":"Front Immunol"},{"key":"2039_CR22","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/joim.13298","volume":"290","author":"F Jansson Sigfrids","year":"2021","unstructured":"Jansson Sigfrids F, Dahlstr\u00f6m EH, Forsblom C, Sandholm N, Harjutsalo V, Taskinen MR, et al. Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes. J Intern Med. 2021;290:632\u201345. https:\/\/doi.org\/10.1111\/joim.13298.","journal-title":"J Intern Med"},{"key":"2039_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.124.035764","volume":"13","author":"C Cui","year":"2024","unstructured":"Cui C, Li P, Qi Y, Song J, Han T, Shang X, et al. Intraindividual discordance between remnant cholesterol and low-density lipoprotein cholesterol associated with incident stroke: results from 2 national cohorts. J Am Heart Assoc. 2024;13:e035764. https:\/\/doi.org\/10.1161\/jaha.124.035764.","journal-title":"J Am Heart Assoc"},{"key":"2039_CR24","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/ndt\/gfad234","volume":"39","author":"J Wang","year":"2024","unstructured":"Wang J, Liu Y, Jin R, Zhao X, Wu Z, Han Z, et al. Intraindividual difference in estimated GFR by creatinine and cystatin C, cognitive trajectories and motoric cognitive risk syndrome. Nephrol Dial Transplant. 2024;39:860\u201372. https:\/\/doi.org\/10.1093\/ndt\/gfad234.","journal-title":"Nephrol Dial Transplant"},{"key":"2039_CR25","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1093\/eurheartj\/ehab432","volume":"42","author":"R Quispe","year":"2021","unstructured":"Quispe R, Martin SS, Michos ED, Lamba I, Blumenthal RS, Saeed A, et al. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. Eur Heart J. 2021;42:4324\u201332. https:\/\/doi.org\/10.1093\/eurheartj\/ehab432.","journal-title":"Eur Heart J"},{"key":"2039_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12916-023-02733-w","volume":"21","author":"Z Wu","year":"2023","unstructured":"Wu Z, Wang J, Zhang H, Pan H, Li Z, Liu Y, et al. Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol. BMC Med. 2023;21:42. https:\/\/doi.org\/10.1186\/s12916-023-02733-w.","journal-title":"BMC Med"},{"key":"2039_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.hjc.2023.05.008","volume":"74","author":"S Wu","year":"2023","unstructured":"Wu S, Su X, Zuo Y, Chen S, Tian X, Xu Q, et al. Discordance between remnant cholesterol and low-density lipoprotein cholesterol predicts arterial stiffness progression. Hellenic J Cardiol. 2023;74:24\u201331. https:\/\/doi.org\/10.1016\/j.hjc.2023.05.008.","journal-title":"Hellenic J Cardiol"},{"key":"2039_CR28","doi-asserted-by":"publisher","first-page":"350","DOI":"10.2337\/dc20-1485","volume":"44","author":"Z Wan","year":"2021","unstructured":"Wan Z, Guo J, Pan A, Chen C, Liu L, Liu G. Association of serum 25-Hydroxyvitamin D concentrations with all-cause and cause-specific mortality among individuals with diabetes. Diabetes Care. 2021;44:350\u20137. https:\/\/doi.org\/10.2337\/dc20-1485.","journal-title":"Diabetes Care"},{"key":"2039_CR29","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2016.10924","volume":"316","author":"M Afkarian","year":"2016","unstructured":"Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988\u20132014. JAMA. 2016;316:602\u201310. https:\/\/doi.org\/10.1001\/jama.2016.10924.","journal-title":"JAMA"},{"key":"2039_CR30","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/s41598-024-51749-6","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu X, Zhang X, Li L, Li Q, Geng H, et al. Association between serum heavy metal levels and diabetic retinopathy in NHANES 2011\u20132020. Sci Rep. 2024;14:1268. https:\/\/doi.org\/10.1038\/s41598-024-51749-6.","journal-title":"Sci Rep"},{"key":"2039_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23:8. https:\/\/doi.org\/10.1186\/s12933-023-02115-9.","journal-title":"Cardiovasc Diabetol"},{"key":"2039_CR32","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/hypertensionaha.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 international society of hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334\u201357. https:\/\/doi.org\/10.1161\/hypertensionaha.120.15026.","journal-title":"Hypertension"},{"key":"2039_CR33","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1021\/acs.analchem.2c03719","volume":"95","author":"SR Shuken","year":"2023","unstructured":"Shuken SR, McNerney MW. Costs and benefits of popular P-value correction methods in three models of quantitative omic experiments. Anal Chem. 2023;95:2732\u201340. https:\/\/doi.org\/10.1021\/acs.analchem.2c03719.","journal-title":"Anal Chem"},{"key":"2039_CR34","doi-asserted-by":"publisher","first-page":"e2128817","DOI":"10.1001\/jamanetworkopen.2021.28817","volume":"4","author":"A Sajja","year":"2021","unstructured":"Sajja A, Park J, Sathiyakumar V, Varghese B, Pallazola VA, Marvel FA, et al. Comparison of methods to estimate low-density lipoprotein cholesterol in patients with high triglyceride levels. JAMA Netw Open. 2021;4:e2128817. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.28817.","journal-title":"JAMA Netw Open"},{"key":"2039_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaf037","author":"JM Kraaijenhof","year":"2025","unstructured":"Kraaijenhof JM, Kerkvliet MJ, Nurmohamed NS, Grefhorst A, Kroon J, Wareham NJ, et al. The role of systemic inflammation in remnant cholesterol associated cardiovascular risk: insights from the EPIC-Norfolk study. Eur J Prev Cardiol. 2025. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf037.","journal-title":"Eur J Prev Cardiol"},{"key":"2039_CR36","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1161\/strokeaha.124.046811","volume":"55","author":"M Han","year":"2024","unstructured":"Han M, Huang K, Shen C, Hu H, Liu F, Li J, et al. Discordant high remnant cholesterol with LDL-C increases the risk of stroke: a Chinese prospective cohort study. Stroke. 2024;55:2066\u201374. https:\/\/doi.org\/10.1161\/strokeaha.124.046811.","journal-title":"Stroke"},{"key":"2039_CR37","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.advnut.2023.05.008","volume":"14","author":"S Talebi","year":"2023","unstructured":"Talebi S, Zeraattalab-Motlagh S, Rahimlou M, Naeini F, Ranjbar M, Talebi A, et al. The association between total protein, animal protein, and animal protein sources with risk of inflammatory bowel diseases: a systematic review and meta-analysis of cohort studies. Adv Nutr. 2023;14:752\u201361. https:\/\/doi.org\/10.1016\/j.advnut.2023.05.008.","journal-title":"Adv Nutr"},{"key":"2039_CR38","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s40200-020-00536-x","volume":"19","author":"M Morvaridi","year":"2020","unstructured":"Morvaridi M, Rayyani E, Jaafari M, Khiabani A, Rahimlou M. The effect of green coffee extract supplementation on cardio metabolic risk factors: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Metab Disord. 2020;19:645\u201360. https:\/\/doi.org\/10.1007\/s40200-020-00536-x.","journal-title":"J Diabetes Metab Disord"},{"key":"2039_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111639","volume":"210","author":"SY Jang","year":"2024","unstructured":"Jang SY, Kang M, Song E, Jang A, Choi KM, Baik SH, et al. Remnant cholesterol is an independent risk factor for the incidence of chronic kidney disease in newly-diagnosed type 2 diabetes: a nationwide population-based study. Diabetes Res Clin Pract. 2024;210:111639. https:\/\/doi.org\/10.1016\/j.diabres.2024.111639.","journal-title":"Diabetes Res Clin Pract"},{"key":"2039_CR40","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1111\/dom.16258","volume":"27","author":"P Karakasis","year":"2025","unstructured":"Karakasis P, Patoulias D, Rizzo M, Fragakis N, Mantzoros CS. Association between remnant cholesterol and chronic kidney disease: systematic review and meta-analysis. Diabetes Obes Metab. 2025;27:2573\u201383. https:\/\/doi.org\/10.1111\/dom.16258.","journal-title":"Diabetes Obes Metab"},{"key":"2039_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1476-511x-13-98","volume":"13","author":"ZY Chen","year":"2014","unstructured":"Chen ZY, Liu SN, Li CN, Sun SJ, Liu Q, Lei L, et al. Atorvastatin helps preserve pancreatic \u03b2 cell function in obese C57BL\/6 J mice and the effect is related to increased pancreas proliferation and amelioration of endoplasmic-reticulum stress. Lipids Health Dis. 2014;13:98. https:\/\/doi.org\/10.1186\/1476-511x-13-98.","journal-title":"Lipids Health Dis"},{"key":"2039_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12933-021-01348-w","volume":"20","author":"S Sokooti","year":"2021","unstructured":"Sokooti S, Flores-Guerrero JL, Heerspink HJL, Connelly MA, Bakker SJL, Dullaart RPF. Triglyceride-rich lipoprotein and LDL particle subfractions and their association with incident type 2 diabetes: the PREVEND study. Cardiovasc Diabetol. 2021;20:156. https:\/\/doi.org\/10.1186\/s12933-021-01348-w.","journal-title":"Cardiovasc Diabetol"},{"key":"2039_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.860575","volume":"9","author":"SN Mousavi","year":"2022","unstructured":"Mousavi SN, Rayyani E, Heshmati J, Tavasolian R, Rahimlou M. Effects of Ramadan and non-ramadan intermittent fasting on gut microbiome. Front Nutr. 2022;9:860575. https:\/\/doi.org\/10.3389\/fnut.2022.860575.","journal-title":"Front Nutr"},{"key":"2039_CR44","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1210\/clinem\/dgab533","volume":"106","author":"D Yu","year":"2021","unstructured":"Yu D, Wang Z, Zhang X, Qu B, Cai Y, Ma S, et al. Remnant cholesterol and cardiovascular mortality in patients with type 2 diabetes and incident diabetic nephropathy. J Clin Endocrinol Metab. 2021;106:3546\u201354. https:\/\/doi.org\/10.1210\/clinem\/dgab533.","journal-title":"J Clin Endocrinol Metab"},{"key":"2039_CR45","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.ajkd.2004.12.012","volume":"45","author":"AY Wang","year":"2005","unstructured":"Wang AY, Lam CW, Wang M, Woo J, Chan IH, Lui SF, et al. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients. Am J Kidney Dis. 2005;45:715\u201329. https:\/\/doi.org\/10.1053\/j.ajkd.2004.12.012.","journal-title":"Am J Kidney Dis"},{"key":"2039_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1409653","volume":"15","author":"D Xu","year":"2024","unstructured":"Xu D, Xie L, Cheng C, Xue F, Sun C. Triglyceride-rich lipoproteins and cardiovascular diseases. Front Endocrinol (Lausanne). 2024;15:1409653. https:\/\/doi.org\/10.3389\/fendo.2024.1409653.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2039_CR47","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.pharmthera.2013.11.008","volume":"141","author":"A Varbo","year":"2014","unstructured":"Varbo A, Benn M, Nordestgaard BG. Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment. Pharmacol Ther. 2014;141:358\u201367. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.11.008.","journal-title":"Pharmacol Ther"},{"key":"2039_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.798958","volume":"8","author":"G Gallo","year":"2021","unstructured":"Gallo G, Volpe M, Savoia C. Endothelial dysfunction in hypertension: current concepts and clinical implications. Front Med (Lausanne). 2021;8:798958. https:\/\/doi.org\/10.3389\/fmed.2021.798958.","journal-title":"Front Med (Lausanne)"},{"key":"2039_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/ehjdh\/ztae080","volume":"6","author":"T Liu","year":"2025","unstructured":"Liu T, Krentz A, Lu L, Curcin V. Machine learning based prediction models for cardiovascular disease risk using electronic health records data: systematic review and meta-analysis. Eur Heart J Digit Health. 2025;6:7\u201322. https:\/\/doi.org\/10.1093\/ehjdh\/ztae080.","journal-title":"Eur Heart J Digit Health"},{"key":"2039_CR50","doi-asserted-by":"publisher","first-page":"e26634","DOI":"10.2196\/26634","volume":"24","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Yang L, Han W, Wu Y, Zhang L, Gao C, et al. Machine learning prediction models for gestational diabetes mellitus: meta-analysis. J Med Internet Res. 2022;24:e26634. https:\/\/doi.org\/10.2196\/26634.","journal-title":"J Med Internet Res"}],"container-title":["Diabetology & Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-02039-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-02039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-02039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:03:38Z","timestamp":1771434218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-025-02039-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2039"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-02039-2","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NHANES has been approved by the National Center for Health Statistics Ethics Review Board, and all participants were provided informed written consent at enrollment. Ethical approval for the validation study was obtained from the Ethics Committee of Clinical Medical College & Affiliated Hospital of Chengdu University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}